The company's lower P/S ratio may be due to its poor revenue...
The company's lower P/S ratio may be due to its poor revenue outlook. The market's expectation of continued weak revenue growth could impact share price. The weaker revenue result compared to industry growth may have led to shareholder pessimism and a depressed P/S ratio.
Deciphera Pharmaceuticals, Inc.'s (NASDAQ:DCPH) Prospects Need A Boost To Lift Shares
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment